Newron Pharmaceuticals SpA (NWRN) — Working Capital to Net Assets Ratio
Newron Pharmaceuticals SpA (NWRN) has a Working Capital to Net Assets ratio of 108.2% as of December 2025. Working capital of CHF-12.04 Million (current assets of CHF38.05 Million minus current liabilities of CHF50.09 Million) is measured against net assets of CHF-11.13 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Newron Pharmaceuticals SpA (NWRN) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Newron Pharmaceuticals SpA Working Capital to Net Assets (2005–2025)
This chart shows how Newron Pharmaceuticals SpA's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of December 2025, the ratio stands at 108.2%, reflecting working capital of CHF-12.04 Million against net assets of CHF-11.13 Million CHF. Check Newron Pharmaceuticals SpA tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Newron Pharmaceuticals SpA (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Newron Pharmaceuticals SpA from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Newron Pharmaceuticals SpA market capitalisation.
| Year | WC/NA Ratio | Working Capital (CHF) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 108.2% | CHF-12.04 Million | CHF-11.13 Million | CHF38.05 Million | CHF50.09 Million | ▼ -2470.5 pp |
| 2024 | 2578.7% | CHF37.60 Million | CHF1.46 Million | CHF61.10 Million | CHF23.51 Million | ▲ +2547.7 pp |
| 2023 | 31.0% | CHF-9.27 Million | CHF-29.91 Million | CHF19.65 Million | CHF28.93 Million | ▲ +198.2 pp |
| 2022 | -167.2% | CHF23.45 Million | CHF-14.03 Million | CHF28.49 Million | CHF5.04 Million | ▼ -1318.5 pp |
| 2021 | 1151.4% | CHF35.77 Million | CHF3.11 Million | CHF39.43 Million | CHF3.65 Million | ▲ +971.7 pp |
| 2020 | 179.6% | CHF30.98 Million | CHF17.25 Million | CHF37.87 Million | CHF6.89 Million | ▲ +71.2 pp |
| 2019 | 108.4% | CHF39.90 Million | CHF36.80 Million | CHF45.49 Million | CHF5.59 Million | ▲ +8.0 pp |
| 2018 | 100.4% | CHF55.08 Million | CHF54.84 Million | CHF59.51 Million | CHF4.43 Million | ▼ -0.1 pp |
| 2017 | 100.5% | CHF68.07 Million | CHF67.72 Million | CHF72.80 Million | CHF4.73 Million | ▲ +1.0 pp |
| 2016 | 99.5% | CHF49.49 Million | CHF49.75 Million | CHF56.14 Million | CHF6.64 Million | ▼ -1.4 pp |
| 2015 | 100.9% | CHF37.46 Million | CHF37.11 Million | CHF43.97 Million | CHF6.51 Million | ▲ +15.8 pp |
| 2014 | 85.1% | CHF24.90 Million | CHF29.26 Million | CHF29.39 Million | CHF4.49 Million | ▲ +10.5 pp |
| 2013 | 74.6% | CHF15.73 Million | CHF21.09 Million | CHF21.80 Million | CHF6.07 Million | ▼ -2.1 pp |
| 2012 | 76.7% | CHF21.16 Million | CHF27.61 Million | CHF32.75 Million | CHF11.59 Million | ▲ +3.7 pp |
| 2011 | 72.9% | CHF4.80 Million | CHF6.58 Million | CHF7.63 Million | CHF2.83 Million | ▲ +3.4 pp |
| 2010 | 69.5% | CHF8.47 Million | CHF12.19 Million | CHF13.11 Million | CHF4.63 Million | ▼ -9.3 pp |
| 2009 | 78.8% | CHF23.08 Million | CHF29.28 Million | CHF31.74 Million | CHF8.65 Million | ▼ -2.4 pp |
| 2008 | 81.3% | CHF37.23 Million | CHF45.81 Million | CHF47.24 Million | CHF10.01 Million | ▼ -22.8 pp |
| 2007 | 104.1% | CHF59.74 Million | CHF57.40 Million | CHF69.52 Million | CHF9.77 Million | ▼ -2.5 pp |
| 2006 | 106.6% | CHF72.34 Million | CHF67.86 Million | CHF85.13 Million | CHF12.79 Million | ▲ +11.7 pp |
| 2005 | 95.0% | CHF16.16 Million | CHF17.02 Million | CHF21.28 Million | CHF5.12 Million | — |